Autolus Therapeutics plc (AUTL)

NASDAQ: AUTL · IEX Real-Time Price · USD

3.380

-0.090 (-2.59%)

At close: Jul 2, 2024, 4:00 PM

3.460

+0.080 (2.37%)

After-hours: Jul 2, 2024, 6:04 PM EDT

Autolus Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	-208.38	-148.84	-142.1	-142.09	-123.85	Upgrade
Depreciation & Amortization	10.62	10.85	12.19	5.66	4.61	Upgrade
Share-Based Compensation	11.2	12.01	9.94	20.11	30.21	Upgrade
Other Operating Activities	40.97	13.66	2.11	-1.43	-12.46	Upgrade
Operating Cash Flow	-145.59	-112.31	-117.86	-117.76	-101.48	Upgrade
Capital Expenditures	-10.99	-10.84	-8.86	-14.68	-18.34	Upgrade
Other Investing Activities	-	-	-	-	-0.33	Upgrade
Investing Cash Flow	-10.99	-10.84	-8.86	-14.68	-18.67	Upgrade
Share Issuance / Repurchase	0.03	163.97	246.03	80.21	115.96	Upgrade
Debt Issued / Paid	0	70	49.49	0	0	Upgrade
Other Financing Activities	-0.91	-10.36	-11.45	-5.8	-7.1	Upgrade
Financing Cash Flow	-0.88	223.61	284.06	74.42	108.86	Upgrade
Exchange Rate Effect	15.03	-28.38	-0.75	0.68	5.16	Upgrade
Net Cash Flow	-142.43	72.09	156.59	-57.35	-6.13	Upgrade
Free Cash Flow	-156.57	-123.15	-126.72	-132.44	-119.83	Upgrade
Free Cash Flow Margin	-9221.02%	-1936.31%	-5438.54%	-7722.39%	-4120.53%	Upgrade
Free Cash Flow Per Share	-0.90	-1.30	-1.76	-2.57	-2.78	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).